Literature DB >> 28889885

Persistent Heparin-Induced Thrombocytopenia Treated With IVIg.

Michelle B Azimov1, Evan D Slater2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28889885     DOI： 10.1016/j.chest.2017.05.044

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study.

Authors:  Binod Dhakal; Lisa Rein; Aniko Szabo; Anand Padmanabhan
Journal:  Chest       Date:  2020-03-26       Impact factor: 9.410

2.  Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.

Authors:  Mehraboon Irani; Eric Siegal; Abhay Jella; Richard Aster; Anand Padmanabhan
Journal:  Transfusion       Date:  2018-12-17       Impact factor: 3.157

3.  Early Utilization of Intravenous Immunoglobulin in Heparin-Induced Thrombocytopenia for Limb Salvaging Purposes.

Authors:  Sarah Abu Kar; Amandeep Kaur; Ahmed M Khan; Dennis Bloomfield
Journal:  Cureus       Date:  2022-03-15

4.  Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia.

Authors:  Jing Dai; Daria Madeeva; Vincent Hayes; Hyun Sook Ahn; Valerie Tutwiler; Gowthami M Arepally; Douglas B Cines; Mortimer Poncz; Lubica Rauova
Journal:  Blood       Date:  2018-06-18       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.